肿瘤科指南

订阅

MedSci主页 / 所有栏目 / 肿瘤科指南

2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病

2020-08-18 日本血液学会 Int J Hematol . 2020 Aug 18.

急性淋巴细胞白血病

2018年日本血液学会(JSH)血液恶性肿瘤—急白血病的管理，本文为急性淋巴细胞白血病／成淋巴细胞白血病管理指南。全文共针对14个临床问题提出指导建议。

中文标题：

2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病

发布机构：

日本血液学会

发布日期：

2020-08-18

简要介绍：

2018年日本血液学会(JSH)血液恶性肿瘤—急白血病的管理，本文为急性淋巴细胞白血病／成淋巴细胞白血病管理指南。全文共针对14个临床问题提出指导建议。

相关资料下载：
[AttachmentFileName(sort=1, fileName=2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病.pdf)] GetToolGuiderByIdResponse(projectId=1, id=8e4be1c00196068e, title=2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病, enTitle=, guiderFrom=Int J Hematol . 2020 Aug 18., authorId=0, author=, summary=2018年日本血液学会(JSH)血液恶性肿瘤&mdash;急白血病的管理，本文为急性淋巴细胞白血病／成淋巴细胞白血病管理指南。全文共针对14个临床问题提出指导建议。, cover=https://img.medsci.cn/2020831/1598804968113_2020535.jpg, journalId=0, articlesId=null, associationId=1460, associationName=日本血液学会, associationIntro=, copyright=0, guiderPublishedTime=Tue Aug 18 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p><span style="color: #373737;">2018年日本血液学会(JSH)血液恶性肿瘤&mdash;急白血病的管理，本文为</span><span style="color: #373737;">急性淋巴细胞白血病／成淋巴细胞白血病</span><span style="color: #373737;">管理指南。全文共针对14个临床问题提出指导建议。</span></p> </div> </div> </div>, tagList=[TagDto(tagId=1425, tagName=急性淋巴细胞白血病)], categoryList=[CategoryDto(categoryId=5, categoryName=肿瘤科, tenant=100), CategoryDto(categoryId=21, categoryName=血液科, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=20620, categoryName=肿瘤医学网, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1425, guiderKeyword=急性淋巴细胞白血病, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=指南, guiderLanguage=1, guiderRegion=4, opened=0, paymentType=, paymentAmount=5, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=4057, appHits=302, showAppHits=0, pcHits=668, showPcHits=3755, likes=0, shares=8, comments=11, approvalStatus=1, publishedTime=Mon Aug 31 00:36:41 CST 2020, publishedTimeString=2020-08-18, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Mon Aug 31 00:29:33 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 06:21:08 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病.pdf)])
2018 JSH实践指南：血液恶性肿瘤—Ⅰ.白血病-3.急性淋巴细胞白血病／成淋巴细胞白血病.pdf
下载请点击：
评论区 (8)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2117378, encodeId=3fc8211e378b2, content=学习了，又增加自身的见识啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=361a8546638, createdName=ms1000000361889575, createdTime=Fri Mar 03 15:58:27 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097125, encodeId=8843209e125f5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=587c8400527, createdName=ms4000000646741653, createdTime=Fri Oct 28 20:09:36 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220415, encodeId=b5141220415ee, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:21 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077085, encodeId=10db10e7085df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Sun Dec 05 15:30:45 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962899, encodeId=472b96289968, content=非常好的指南，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6a5a5492784, createdName=涛涛不绝, createdTime=Wed May 05 21:00:48 CST 2021, time=2021-05-05, status=1, ipAttribution=)]
    2023-03-03 ms1000000361889575 来自广东省

    学习了，又增加自身的见识啦

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=2117378, encodeId=3fc8211e378b2, content=学习了，又增加自身的见识啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=361a8546638, createdName=ms1000000361889575, createdTime=Fri Mar 03 15:58:27 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097125, encodeId=8843209e125f5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=587c8400527, createdName=ms4000000646741653, createdTime=Fri Oct 28 20:09:36 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220415, encodeId=b5141220415ee, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:21 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077085, encodeId=10db10e7085df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Sun Dec 05 15:30:45 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962899, encodeId=472b96289968, content=非常好的指南，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6a5a5492784, createdName=涛涛不绝, createdTime=Wed May 05 21:00:48 CST 2021, time=2021-05-05, status=1, ipAttribution=)]
    2022-10-28 ms4000000646741653

    。

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=2117378, encodeId=3fc8211e378b2, content=学习了，又增加自身的见识啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=361a8546638, createdName=ms1000000361889575, createdTime=Fri Mar 03 15:58:27 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097125, encodeId=8843209e125f5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=587c8400527, createdName=ms4000000646741653, createdTime=Fri Oct 28 20:09:36 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220415, encodeId=b5141220415ee, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:21 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077085, encodeId=10db10e7085df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Sun Dec 05 15:30:45 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962899, encodeId=472b96289968, content=非常好的指南，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6a5a5492784, createdName=涛涛不绝, createdTime=Wed May 05 21:00:48 CST 2021, time=2021-05-05, status=1, ipAttribution=)]
    2022-05-17 赛华佗

    #急性淋巴细胞白血病#

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=2117378, encodeId=3fc8211e378b2, content=学习了，又增加自身的见识啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=361a8546638, createdName=ms1000000361889575, createdTime=Fri Mar 03 15:58:27 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097125, encodeId=8843209e125f5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=587c8400527, createdName=ms4000000646741653, createdTime=Fri Oct 28 20:09:36 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220415, encodeId=b5141220415ee, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:21 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077085, encodeId=10db10e7085df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Sun Dec 05 15:30:45 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962899, encodeId=472b96289968, content=非常好的指南，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6a5a5492784, createdName=涛涛不绝, createdTime=Wed May 05 21:00:48 CST 2021, time=2021-05-05, status=1, ipAttribution=)]
    2021-12-05 denglimoxiaoran

    学习

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=2117378, encodeId=3fc8211e378b2, content=学习了，又增加自身的见识啦, beContent=null, objectType=guider, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=361a8546638, createdName=ms1000000361889575, createdTime=Fri Mar 03 15:58:27 CST 2023, time=2023-03-03, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=2097125, encodeId=8843209e125f5, content=。, beContent=null, objectType=guider, channel=null, level=null, likeNumber=35, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=587c8400527, createdName=ms4000000646741653, createdTime=Fri Oct 28 20:09:36 CST 2022, time=2022-10-28, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1220415, encodeId=b5141220415ee, content=<a href='/topic/show?id=994952328d2' target=_blank style='color:#2F92EE;'>#急性淋巴细胞白血病#</a>, beContent=null, objectType=guider, channel=null, level=null, likeNumber=54, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=52328, encryptionId=994952328d2, topicName=急性淋巴细胞白血病)], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20220519/c2ab253484ee4527a2d4e9589a4821ac/45de9bf494a54becb2ea4369c9d11e85.jpg, createdBy=7a3710, createdName=赛华佗, createdTime=Tue May 17 16:42:21 CST 2022, time=2022-05-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1077085, encodeId=10db10e7085df, content=学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f4f22999147, createdName=denglimoxiaoran, createdTime=Sun Dec 05 15:30:45 CST 2021, time=2021-12-05, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=962899, encodeId=472b96289968, content=非常好的指南，学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=6a5a5492784, createdName=涛涛不绝, createdTime=Wed May 05 21:00:48 CST 2021, time=2021-05-05, status=1, ipAttribution=)]
    2021-05-05 涛涛不绝

    非常好的指南，学习了

    0

相关指南

2018 北美专家共识建议：成人急性淋巴细胞白血病可测量残留病评估和管理

国外血液科相关专家小组 · 2018-11-05

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-11-01

儿童急性淋巴细胞白血病诊疗规范（2018版）

中华人民共和国国家卫生健康委员会 · 2018-10-08

2017 日本造血和淋巴组织肿瘤指南：急性淋巴细胞白血病／成淋巴细胞性淋巴瘤

日本血液学会(JSH,Japanese Society of Hematology) · 2017-10-24

拓展阅读

2015 培门冬酶治疗急性淋巴细胞白血病和恶性淋巴瘤中国专家共识

中国临床肿瘤学会(CSCO,Chinese Society of Clinical Oncology) · 2015-12-30

《中国成人急性淋巴细胞白血病诊断与治疗的指南（2016版）》解读

暂未更新 · 2017-09-10

2017 日本造血和淋巴组织肿瘤指南：急性淋巴细胞白血病／成淋巴细胞性淋巴瘤

日本血液学会(JSH,Japanese Society of Hematology) · 2017-10-24

儿童急性淋巴细胞白血病诊疗规范（2018版）

中华人民共和国国家卫生健康委员会 · 2018-10-08

2018 EWALL/EBMT立场声明：造血干细胞移植治疗成人费城染色体阴性急性淋巴细胞白血病首次缓解

欧洲血液和骨髓移植小组(EBMT,European Group for Blood and Marrow Transplantation) · 2018-11-01

2018 北美专家共识建议：成人急性淋巴细胞白血病可测量残留病评估和管理

国外血液科相关专家小组 · 2018-11-05